A clinical formulation indicated for Neurology and Pain Relief. This medication manages muscle spasticity and involuntary muscle contractions to improve overall physical comfort.
A short-acting muscle relaxant intended to alleviate muscle spasticity and developed to manage painful spasms to support improved motor function and rest.
Mechanism of Action
It stimulates alpha-2 adrenergic receptors in the spinal cord. This reduces the release of excitatory amino acids, inhibiting motor neuron activity and relaxing muscles.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
3–6 hours
Contraindications
Concurrent use of ciprofloxacin, Concurrent use of fluvoxamine, Severe liver disease
Severe Adverse Events
Liver toxicity, Hallucinations, Severe hypotension, Fainting, Psychosis
Information for Tizanidine is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
